Examining the uncertain origin and management role of martens on Prince of Wales Island,Alaska

Conservation biologists are generally united in efforts to curtail the spread of non‐native species globally. However, the colonization history of a species is not always certain, and whether a species is considered non‐native or native depends on the conservation benchmark. Such ambiguities have led to inconsistent management. Within the Tongass National Forest of Alaska, the status of American marten (Martes americana) on the largest, most biologically diverse and deforested island, Prince of Wales (POW), is unclear. Ten martens were released to POW in the early 1930s, and it was generally believed to be the founding event, although this has been questioned. The uncertainty surrounding when and how martens colonized POW complicates management, especially because martens were selected as a design species for the Tongass. To explore the history of martens of POW we reviewed other plausible routes of colonization; genetically and isotopically analyzed putative marten fossils deposited in the late Pleistocene and early Holocene to verify marten occupancy of POW; and used contemporary genetic data from martens on POW and the mainland in coalescent simulations to identify the probable source of the present‐day marten population on POW. We found evidence for multiple routes of colonization by forest‐associated mammals beginning in the Holocene, which were likely used by American martens to naturally colonize POW. Although we cannot rule out human‐assisted movement of martens by Alaskan Natives or fur trappers, we suggest that martens be managed for persistence on POW. More generally, our findings illustrate the difficulty of labeling species as non‐native or native, even when genetic and paleo‐ecological data are available, and support the notion that community resilience or species invasiveness should be prioritized when making management decisions rather than more subjective and less certain conservation benchmarks.     

Utilization of prenatal cytogenetic diagnosis in women of advanced maternal age in Australia, 1979–1982

This paper reports the results of a complete national survey to measure utilization rates of prenatal cytogenetic diagnosis (P.C.D.) in women of advanced maternal age in Australia. P.C.D. has been available throughout Australia for the last decade. Every laboratory in Australia providing a P.C.D. service for the years 1979–1982 took part in this study. Utilization rates (both National and State rates) by ages of mothers, are presented. Big interstate differences exist. The 1982 National P.C.D. utilization rate for pregnant women who were 40 years of age and over was 38.8 per cent, and this rate has shown an average annual increase of 9 per cent. In those four States which offered P.C.D. to pregnant women of 35 years or over the median utilization rate was 20 per cent. These Australian rates indicate an under-utilization of P.C.D. services with (in 1982) 50–80 per cent of ‘at risk’ women not being tested. Factors which influence this are discussed.     

Health benefits due to reductions of CO levels

A method is presented by which an upper limit of the adverse health effect of existing ambient CO concentrations on the U. S. population can be estimated. The method is based upon estimating the primary human physiological response to CO concentrations (COHb%) for the population in terms of person-hour-COHb>1.5% resulting from the time exposure of the population to CO concentrations in excess of the federally designated ambient air quality standard. The estimates of person-hour-COHb>1.5% are for exposures only to ambient CO concentrations and do not take into account the additional CO exposure for people who smoke or have occupational exposures.We estimate that there were up to 30.9×10⁹ person-hour-COHb>1.5% in 1973 due to ambient concentrations in excess of the ambient 8-hour CO standard, with approximately 5×10⁹ person-hour-COHb>1.5% occurring West of the Continental Divide and 25.9>10⁹ person-hour-COHb>1.5% occuring East of the Continental Divide; of these 21.3×10⁹ personhour-COHb>1.5% occurred in New York City. It was also estimated that a 60% reduction in 1973 ambient concentrations of CO (corresponding to an automotive emmision standard of less than 15 g/mile) would be needed to reduce to zero the person-hour-COHb>1.5%. The maximum estimated effects on the U.S. population of increases in ambient CO concentration above 1973 levels are also presented.     

A comparison of concentrations of polycyclic aromatic compounds detected in dust samples from various regions of the world

Settled house dust can be a source of human exposure to toxic polycyclic aromatic hydrocarbons (PAHs) through non-dietary ingestion and dermal contact. Information regarding the concentrations of various contaminants in house dust would be useful in estimating the risk associated with exposure to these compounds. This study reports on the surface loading, variability and distribution of PAHs in settled house dust collected from homes in three locations: Sumgayit, Azerbaijan; Shanxi Province, China; and southern Texas, United States. The highest PAH floor surface loadings were observed in China, followed by Azerbaijan and Texas. Median concentrations of high molecular weight (four ring and larger) PAHs ranged from a low of 0.11 microg/m(2) in Texas, to 2.9 microg/m(2) in Azerbaijan and 162 microg/m(2) in China. These trends in total surface loading and relative carcinogenicity indicate that the risk of health effects from exposure to PAHs in house dust is highest in the Chinese population and lowest in the Texas population. As anticipated, variability among dust samples from different houses within the same region was high, with coefficients of variation greater than 100%. Alkylated PAHs comprised 30-50% of the total mass of PAHs. Based on a comparison of the composition of specific components, PAHs in China and Azerbaijan were determined to be derived mainly from combustion sources rather than from unburned fossil fuels such as petroleum. These results, coupled with ongoing investigation of appropriate PAH exposure biomarkers in humans, will guide future efforts to identify ways to reduce exposures in the study areas.